$0.661
+0.033 (+4.92%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RDHL Prediction & Forecast by Similar Chart Analysis
Alphio's RDHL stock price prediction model matches the current Redhill Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.69 (+3.74%). The 1-week path is $0.72 (+8.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Redhill Biopharma Ltd Stock?
Redhill Biopharma Ltd (RDHL) is currently not a strong buy due to its high RSI of 72.825, indicating overbought conditions, and a forward P/E ratio of 1428.57, which suggests that the stock is highly overvalued compared to its earnings potential. While there is potential for growth due to the recent FDA designations, the company has a significant risk with a current ratio of 0.54, indicating potential liquidity issues.
RDHL stock price ended at $0.66 on Friday, after rising +4.92%
Redhill Biopharma Ltd (RDHL) last closed at $0.661, gaining +4.92%. These facts feed the 1-day and 1-week RDHL price prediction above.
Analyst Consensus
Redhill Biopharma Ltd (RDHL): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Redhill Biopharma Ltd (RDHL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RDHL, ranked by similarity.
Seasonality analysis for RDHL
Historically the probability of a positive August return for RDHL is 0.00%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.